A Open-Label Long-Term Extension Study To Evaluate The Safety And Efficacy Of Venlafaxine Er In Adult Outpatients With Major Depressive Disorder [EXTENSION STUDY OF 700207103]

Trial Profile

A Open-Label Long-Term Extension Study To Evaluate The Safety And Efficacy Of Venlafaxine Er In Adult Outpatients With Major Depressive Disorder [EXTENSION STUDY OF 700207103]

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2016

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 20 Feb 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
    • 15 Jan 2013 New trial record
    • 02 Mar 2012 Trial status changed from not yet recruting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top